Skip to content

Effects of perinatal maternal ureaplasma urealyticum infection on neonatal general motor evaluation and late neurodevelopmental outcomes

Effects of perinatal maternal ureaplasma urealyticum infection on neonatal general motor evaluation and late neurodevelopmental outcomes

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200061282
Enrollment
Unknown
Registered
2022-06-19
Start date
2022-06-18
Completion date
Unknown
Last updated
2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuromotor development is backward

Interventions

Group 1 :
Group 2:

Sponsors

Xuzhou Rehabilitation Hospital, Jiangsu Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 6 Years

Inclusion criteria

Inclusion criteria: 1. During the perinatal period, the mother should be tested for Ureaplasma Urealyticum in our hospital; 2. High-risk infants undergo at least one whole-body motor assessment during the writhing phase and restless movement phase; 3. High-risk infants can receive follow-up in the later stage and the follow-up results are clear; 4. The informed consent of the guardian of the child and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. The child's family has hereditary metabolic diseases; 2. The child suffers from congenital heart disease; 3. Children with epilepsy; 4. The child's guardian refuses the child to receive follow-up or the outcome of the child's follow-up is not clear; 5. Brachial plexus damage affects the physical activities of one side of the upper limb during childbirth; 6. The researchers believe that there are other conditions that are not suitable for inclusion; 7. Family members refused to sign the informed consent during the follow-up period.

Design outcomes

Primary

MeasureTime frame
Peabody Motor Development Score;Results of total body motion assessment;Determination of ureaplasma urealyticum;

Countries

China

Contacts

Public ContactWei Chen

Xuzhou Rehabilitation Hospital, Jiangsu Province

whnxzmu@163.com+86 18895666781

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026